Centene Corporation Common Stock (CNC)
29.14
-1.27 (-4.18%)
NYSE · Last Trade: Jul 17th, 9:13 PM EDT
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 17, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · July 17, 2025
Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety over government-sponsored healthcare.
Via Benzinga · July 17, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Elevance Stock Slips After Wells Fargo Cuts Price Target Ahead Of Q2 Earnings: Retail’s Not Pessimistic Yetstocktwits.com
Via Stocktwits · July 15, 2025
Elevance Health topped Q2 revenue estimates but missed on EPS and cut its 2025 guidance due to rising medical cost trends in Medicaid and ACA.
Via Benzinga · July 17, 2025
The health insurer now expects its adjusted net income per diluted share to be approximately $30.00, down from its previous guidance of $34.15 to $34.85.
Via Stocktwits · July 17, 2025
UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about financial reporting and deal transparency.
Via Benzinga · July 16, 2025
Via Benzinga · July 16, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · July 16, 2025
Centene Corp has dropped over 40%, and Adhishthana principles suggest that the decline signals deeper structural issues.
Via Benzinga · July 14, 2025
UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across the sector.
Via Benzinga · July 14, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Via StockStory · July 14, 2025
NVDA stock hit a $4 trillion market cap, but tariff concerns brought back the bears; next week brings a slew of economic data and the start of earnings season
Via MarketBeat · July 12, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · July 12, 2025
Via Benzinga · July 11, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · July 9, 2025
Centene just crashed. But, price target updates signal the selloff is overdone, with 50% upside in play. However, the "Big Beautiful Bill" is another curveball.
Via MarketBeat · July 8, 2025
UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.
Via Benzinga · July 7, 2025
Molina Healthcare is citing rising medical costs across its Medicaid, Medicare, and state marketplace businesses.
Via Benzinga · July 7, 2025
10 worst performing large-cap stocks in holiday-shortened week, including Centene Corp, Molina Healthcare, and Circle Internet Group.
Via Benzinga · July 6, 2025
Via Benzinga · July 5, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active S&P500 stocks in today's session.
Via Chartmill · July 3, 2025
Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.
Via Benzinga · July 3, 2025